DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial
Background Although endovascular stenting is considered an effective and safe therapeutic option for symptomatic intracranial atherosclerotic disease (sICAD), an elevated rate of restenosis remains an important issue for the conventional bare-metal stent (BMS). Recent evidence from observational stu...
Saved in:
| Main Authors: | Dapeng Mo, Zhongrong Miao, Sheng Guan, Yuesong Pan, Xiaoqing Li, Chuan Qin, Xu Tong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
|
| Series: | Stroke and Vascular Neurology |
| Online Access: | https://svn.bmj.com/content/early/2024/07/23/svn-2024-003259.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endovascular correction of complicated stenotic lesions in brachycephalic arteries
by: A. I. Beliy, et al.
Published: (2019-02-01) -
Experience of endovascular treatment of occlusion-stenotic lesions of cerebral arteries.
by: Yu. V. Cherednichenko
Published: (2016-03-01) -
Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease
by: Yingkun Chen, et al.
Published: (2025-05-01) -
Drug-coated balloon angioplasty versus conventional angioplasty for symptomatic non-acute intracranial artery occlusion
by: Kaiyue Dong, et al.
Published: (2025-08-01) -
Role of thromboelastography in predicting stroke risk after endovascular treatment for symptomatic intracranial atherosclerotic stenosis
by: Bo Zhou, et al.
Published: (2025-07-01)